PMID- 27016609 OWN - NLM STAT- MEDLINE DCOM- 20170728 LR - 20171109 IS - 1550-6606 (Electronic) IS - 0022-1767 (Linking) VI - 196 IP - 9 DP - 2016 May 1 TI - TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease. PG - 3570-80 LID - 10.4049/jimmunol.1501591 [doi] AB - T cell Ig and ITIM domain receptor (TIGIT), expressed on T, NK, and regulatory T cells, is known as an inhibitory molecule that limits autoimmunity, antiviral and antitumor immunity. In this report, we demonstrate that TIGIT enhances Th2 immunity. TIGIT expression was upregulated in activated Th2 cells from mice with experimental allergic disease and in Th2 polarization cultures. In addition, its high-affinity ligand CD155 was upregulated in mediastinal lymph node dendritic cells from allergic mice. In an in vitro setting, we observed that Tigit expression in Th2 cells and its interaction with CD155 expressed in dendritic cells were important during the development of Th2 responses. In addition, blockade of TIGIT inhibited Th2, but had no effect on either Th1 or Th17 polarization. In vivo blockade of TIGIT suppressed hallmarks of allergic airway disease, such as lung eosinophilia, goblet cell hyperplasia, Ag-specific Th2 responses, and IgE production, and reduced numbers of T follicular helper and effector Th2 cells. Thus, TIGIT is critical for Th2 immunity and can be used as a therapeutic target, especially in light of recent findings showing TIGIT locus hypomethylation in T cells from pediatric patients with allergic asthma. CI - Copyright (c) 2016 by The American Association of Immunologists, Inc. FAU - Kourepini, Evangelia AU - Kourepini E AUID- ORCID: 0000-0002-2299-1007 AD - Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 115 27, Greece; and. FAU - Paschalidis, Nikolaos AU - Paschalidis N AD - Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 115 27, Greece; and. FAU - Simoes, Davina C M AU - Simoes DC AD - Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 115 27, Greece; and. FAU - Aggelakopoulou, Maria AU - Aggelakopoulou M AD - Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 115 27, Greece; and. FAU - Grogan, Jane L AU - Grogan JL AD - Department of Cancer Immunology, Genentech, South San Francisco, CA 94080. FAU - Panoutsakopoulou, Vily AU - Panoutsakopoulou V AUID- ORCID: 0000-0002-1569-1508 AD - Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens 115 27, Greece; and vpan@bioacademy.gr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160325 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Cytokines) RN - 0 (Receptors, Immunologic) RN - 0 (Receptors, Virus) RN - 0 (T cell Ig and ITIM domain protein, mouse) RN - 0 (poliovirus receptor) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Animals MH - Cytokines/immunology MH - Dendritic Cells/immunology MH - Female MH - Goblet Cells/immunology MH - Hyperplasia/immunology MH - Hypersensitivity/*immunology MH - Immunoglobulin E/biosynthesis/immunology MH - *Immunologic Memory MH - Lymphocyte Activation MH - Mice MH - Mice, Inbred BALB C MH - Pulmonary Eosinophilia/immunology MH - Receptors, Immunologic/genetics/*metabolism MH - Receptors, Virus/genetics MH - Th17 Cells/immunology MH - Th2 Cells/*immunology/physiology EDAT- 2016/03/27 06:00 MHDA- 2017/07/29 06:00 CRDT- 2016/03/27 06:00 PHST- 2015/07/17 00:00 [received] PHST- 2016/02/23 00:00 [accepted] PHST- 2016/03/27 06:00 [entrez] PHST- 2016/03/27 06:00 [pubmed] PHST- 2017/07/29 06:00 [medline] AID - jimmunol.1501591 [pii] AID - 10.4049/jimmunol.1501591 [doi] PST - ppublish SO - J Immunol. 2016 May 1;196(9):3570-80. doi: 10.4049/jimmunol.1501591. Epub 2016 Mar 25.